Company intelligence / Profile preview
Asacpharma
Alicante, Alicante, Spainlaboratoriosapi.com ↗
- Ownership
- Private
- Employees
- ~400
- Development stage
- Commercial
01
Overview
Asac Pharmaceutical Immunology is a fully commercial-stage company producing allergenic and bacterial immunotherapy products, including allergenic extracts for diagnosis and hyposensitization, as well as bacterial vaccines and autovaccines. All products are manufactured under EU GMP and EMA guidelines. The company has a presence in multiple countries and a history of international exports but does not appear to sponsor advanced global clinical trials of novel molecular entities.
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- VaccineBiologicBacterial vaccineAllergenic extract
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Distribution agreements in Portugal and Latin AmericaAcademic collaborations (R&D with universities)
Beyond the preview
Go deeper on Asacpharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Asacpharma.